Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
{{custom_author.name}}, {{article.zuoZheEn}}
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
[{{custom_ref.label}}] |
{{custom_citation.content}}
CrossRef
Pubmed
arXiv
Google scholar
|
/
〈 | 〉 |